Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 6/2019

01-12-2019 | Correction

Correction to: Retrospective multicentric study of pituitary incidentalomas

Authors: Patricia Fainstein-Day, Mirtha Guitelman, Rosa Artese, León Fiszledjer, Alberto Chervin, Nicolás Marcelo Vitale, Graciela Stalldecker, Valeria De Miguel, Dora Cornaló, Analía Alfieri, María Susana Susana Mallea-Gil

Published in: Pituitary | Issue 6/2019

Login to get access

Excerpt

Unfortunately one of the co-author’s first name and last name had been wrongly published. The correct version is Maria Susana Mallea Gil and not Maria Susana, and Mallea Gil as published. …
Metadata
Title
Correction to: Retrospective multicentric study of pituitary incidentalomas
Authors
Patricia Fainstein-Day
Mirtha Guitelman
Rosa Artese
León Fiszledjer
Alberto Chervin
Nicolás Marcelo Vitale
Graciela Stalldecker
Valeria De Miguel
Dora Cornaló
Analía Alfieri
María Susana Susana Mallea-Gil
Publication date
01-12-2019
Publisher
Springer US
Published in
Pituitary / Issue 6/2019
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-019-00995-3

Other articles of this Issue 6/2019

Pituitary 6/2019 Go to the issue

OriginalPaper

Surgical resection of granular cell tumor of the sellar region: three indications

OriginalPaper

Development of a novel patient-reported measure for acromegaly: the Acro-TSQ

OriginalPaper

The acromegalic spine: fractures, deformities and spinopelvic balance

OriginalPaper

Double pituitary adenomas in a large surgical series

OriginalPaper

Predictors of hypopituitarism due to vasculotoxic snake bite with acute kidney injury

OriginalPaper

Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing’s disease
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits